# FDG PET/CT in Breast Cancer Bone Mets

> **NCT01996046** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 75 (estimated)

## Conditions studied

- Estrogen Receptor Positive Breast Cancer
- Bone Metastases

## Interventions

- **OTHER:** FDG PET/CT scan

## Key facts

- **NCT ID:** NCT01996046
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-09
- **Primary completion:** 2023-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01996046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01996046, "FDG PET/CT in Breast Cancer Bone Mets". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01996046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*